Some proteins can change their fold from normal to a specific alternative form, called prion, which is able to catalyze this change (1). In man and animals such process causes prion diseases like Creutzfeldt-Jacob disease, bovine spongiform encephalopathy, and scrapie of sheep. A similar autocatalytic mechanism is shared by human amyloid diseases, which are noninfectious, in contrast to prion diseases (2). In yeast, there are several proteins, which can undergo prion-like structural conversion. The most studied of them are translation termination factor eRF3, also called Sup35, and Ure2 involved in regulation of nitrogen metabolism (3 was not lost (9). Hsp104 was shown to break large aggregates of denatured protein into smaller pieces (10, 11). We proposed that Hsp104 acts similarly on fiber-shaped prion polymers, thus fragmenting them into shorter polymers and increasing their number (12). This is essential for their inheritance and accelerates the prion conversion by multiplying the ends of prion polymers, where the conversion occurs. The overproduction of Hsp104 should cause excessive fragmentation, increased levels of soluble Sup35, and possibly [PSI ϩ ] loss. An alternative model proposed that Hsp104 is primarily required to facilitate the prion conversion in one or another way (13,14).These two models may be distinguished, since they make different predictions for alteration of the size of prion particles upon inhibition of the Hsp104 function. By the former model, the size should increase due to blocked fragmentation, while by the latter it should stay constant or decrease due to block of polymerization. Recent studies provided some support for the "fragmentation" model. Decrease of the Hsp104 expression caused increase in the size of Sup35 prion aggregates, suggesting decreased disaggregation by Hsp104 (15). The activity of Hsp104 is inhibited by growing yeast cells in the presence of 3-5 mM guanidine HCl (GuHCl) 1 (16). Such treatment cures efficiently [PSI ϩ ] (17) and other known yeast prions. Study of the kinetics of [PSI ϩ ] loss in the presence of GuHCl allowed concluding that it blocks replication of prion "seeds" (18,19). Thus, Hsp104 inhibition correlates with the block of fragmentation (replication) of prion particles (seeds). However, in these experiments the relation of the studied prion entities to the Sup35 polymers considered by the above models was not characterized. The prion seeds were defined genetically, but their physical nature was not studied. In the work (15) the size of